Replies to post #160699 on Biotech Values

[DewDiligence]

Do you agree that FDA may want to see the full safety database from the GALA study? Speaking objectively (rather than as a MNTA investor), that's what I would probably ask for if I were an FDA reviewer.

[genisi]

Teva's CEO said they are prepared with aggressive launch of 3x week Copaxone if approved by FDA in 2014.